A Study of ATG-201 in Adult Participants With Autoimmune Diseases
NCT07732309
·
clinicaltrials.gov ↗
PHASE1
Phase
NOT_YET_RECRUITING
Status
149
Enrollment
INDUSTRY
Sponsor class
Conditions
Systemic Lupus Erythematosus
Systemic Sclerosis (SSc)
Sjogren's Disease
Autoimmune Diseases
Interventions
DRUG:
ATG-201
Sponsor
Antengene Biologics Limited